SAI - Detailed view

COSENTYX Trockensub 150 mg Durchstf

Drug

Name

Cosentyx, Pulver zur Herstellung einer Injektionslösung

Field of application

Plaque Psoriasis bei Erwachsenen und Kindern ab 6 Jahren, ankylosierende Spondylitis, psoriatische Arthritis, nicht-röntgenologische axiale Spondyloarthritis, Hidradenitis suppurativa

ATC

L04AC10 - SECUKINUMAB

07.15.0. – immunosuppressants

Use

HAM – Human medicine

pharmaceutical form

PULVL – Powder for solution for injection

Remedy code

BT – biological medicines

Dispensing categories

B – Dispensed on prescription by a physician or veterinarian (B)

Authorisation status

Z – approved

Authorisation number

63295

Initial registration date

2/20/2015

Expiry date

12/31/9999

Dosage strength

Name

Cosentyx 150 mg, Pulver zur Herstellung einer Injektionslösung

Field of application

Plaque Psoriasis bei Erwachsenen und Kindern ab 6 Jahren, ankylosierende Spondylitis, psoriatische Arthritis, nicht-röntgenologische axiale Spondyloarthritis, Hidradenitis suppurativa

Dosage strength number

Authorisation status

Z – approved

Package

GTIN**

7680632950015

Trade status*

No information made available

Status

A/R – Authorised / referenced

Package size

1 vial(s)

Package code

001

Authorisation status

Z – approved

Declaration

Component Freeze-dried preparation

Active substance

150 mg secukinumabum

Excipient

saccharum
histidinum
histidini hydrochloridum monohydricum
polysorbatum 80

Spezialitätenliste***

Status

Date of deletion

Compulsory until

Public price (CHF)

602.45

Limitation points

None

Limitation

Yes

SB Deductible

10%

Generic

Authorisation holder

GLN**

7601001300477

Address

Novartis Pharma Schweiz AG
6343 Risch (ZG)

Date of revision of the text

7/4/2024

Information for prof.

Leaflet

Report error

Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.